Sexual Therapy and Rehabilitation After Treatment for Ovarian Cancer (START-OC): A Pilot Intervention
This research study is evaluating an educational intervention for women who have experienced changes in sexual function after treatment for ovarian cancer.
|Condition or Disease||Intervention/Treatment||Phase|
The purpose of this research is to study the effectiveness of an educational intervention for women who have experienced changes in sexual function after treatment for ovarian cancer. The aim is to develop an effective intervention to help women manage these changes and restore sexual health and functioning. This study consists of attending a group educational session followed by a one-on-one telephone counseling session.
Arms and Interventions
|Experimental: Support Group|
One group educational session will include information on resources, self-help strategies, and relaxation techniques. One telephone coaching session after the group session Or Pilot webinar format of the educational session
Behavioral: Group Session
Behavioral: Telephone Coaching Session
Primary Outcome Measures
- Change in sexual dysfunction will be assessed by change on the Female Sexual Function Index (FSFI). [Baseline, 2 month Post Intervention, 6 Month Post Intervention]
Secondary Outcome Measures
- Change in sexual self-efficacy will be assessed by change on the Sexual Self-Efficacy Scale [Baseline, 2 Month Post Intervention, 6 Month Post Intervention]
- Improvement in sexual knowledge will be assessed by change on the Sexual Knowledge after Ovarian Cancer questionnaire [Baseline, 2 Month Post Intervention, 6 Month Post Intervention]
- Change in psychological distress will be assessed by change on the BSI-18 (Brief Symptom Inventory) [Baseline, 2 Month Post Intervention, 6 Month Post Intervention]
- Feasibility of conducting a group sexual health intervention via webinar format will be assessed with descriptive data and qualitative feedback from participants [Baseline, 2 Month Post Intervention, 6 Month Post Intervention]
To explore and describe women's experience of webinar platform.
Women diagnosed with Stage1-IV ovarian cancer
Prognosis of at least one year to live (as assessed by provider)
Endorsement of at least one sexual symptom (see Appendix A for eligibility screening)
Signed informed consent
History of pelvic radiation
Cognitive impairment which would interfere with the ability to participate in the study (as assessed by provider)
Contacts and Locations
|1||Massachusetts General Hospital||Boston||Massachusetts||United States||02114|
|2||Dana Farber Cancer Institute||Boston||Massachusetts||United States||02115|
Sponsors and Collaborators
- Dana-Farber Cancer Institute
- Patty Brisben Foundation For Women's Sexual Health
- Principal Investigator: Sharon Bober, Ph.D, Dana-Farber Cancer Institute
Study Documents (Full-Text)None provided.